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ABSTRACT
The myogenic differentiation 1 (MyoD) gene is a
master regulator of myogenesis. We previously
reported that the expression of MyoD mRNA
oscillates over 24 h in skeletal muscle and that the
circadian clock transcription factors, BMAL1 (brain
and muscle ARNT-like 1) and CLOCK (circadian
locomotor output cycles kaput), were bound to the
core enhancer (CE) of the MyoD gene in vivo. In this
study, we provide in vivo and in vitro evidence that
the CE is necessary for circadian expression of
MyoD in adult muscle. Gel shift assays identified a
conserved non-canonical E-box within the CE that
is bound by CLOCK and BMAL1. Functional analysis
revealed that this E-box was required for full activa-
tion by BMAL1/CLOCK and for in vitro circadian
oscillation. Expression profiling of muscle of
CEloxP/loxP mice found approximately 1300 genes
mis-expressed relative to wild-type. Based on the
informatics results, we analyzed the respiratory
function of mitochondria isolated from wild-type
and CEloxP/loxP mice. These assays determined that
State 5 respiration was significantly reduced in
CEloxP/loxP muscle. The results of this work identify
a novel element in the MyoD enhancer that confers
circadian regulation to MyoD in skeletal muscle and
suggest that loss of circadian regulation leads to
changes in myogenic expression and downstream
mitochondrial function.
INTRODUCTION
The MyoD (myogenic differentiation 1) gene is the
founding member of the myogenic regulatory factor
family of transcription factors and is known to have a
central role in myogenesis (1). In adult skeletal muscle,
MyoD is thought to function primarily in the myogenic
differentiation of satellite cells during muscle regeneration
(2,3). Recently, however, MyoD expression has been
found to oscillate over a 24 h period in both mouse and
rat skeletal muscle (4,5). Andrews and colleagues (4) also
determined that MyoD was a direct transcriptional target
of the molecular clock. Both BMAL1 and CLOCK were
found to bind to the MyoD core enhancer (CE) 20 kb
upstream (6). The molecular link between the core clock
and MyoD implicated a role for the circadian expression
of MyoD in skeletal muscle homeostasis. This was sup-
ported by phenotypic analysis of muscle from two
different genetic mouse models in which expression of
the core circadian genes, Bmal1 or Clock, were disrupted
(4). Andrews and colleagues (4) reported that in skeletal
muscle of clock-compromised mice MyoD expression did
not oscillate and this was associated with a disruption
of muscle structure and diminished mechanical function.
The CE is a relatively small enhancer of 258 bp and
resides 20 kb upstream of the MyoD transcription start
site. Previous studies have shown that loss of the CE
affects expression of MyoD in all embryonic skeletal
muscle compartments, including somitic myotomes, limb
buds and branchial arches (6,7). The CE appears to be
primarily regulated by a positive control mechanism
operating through multiple, discrete cis-elements that are
scattered throughout the enhancer (8,9). Kablar et al. (7)
reported that deletion of the CE in the mouse caused
a reduction in MyoD mRNA expression in both
embryos and neonates and resulted in a delay in muscle
differentiation. In contrast to its role during development,
the CE was found to be dispensable for expression during
late fetal stages and was assumed to be inactive in adult
muscle (10). Thus, these studies showed that the CE
was critical for initiation of MyoD transcription during
development but was argued to be not necessary for
expression of MyoD in adult skeletal muscle (8,11).
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The molecular clock that governs circadian rhythms can
be described as a transcription–translation feedback loop
(12). The forward arm of the molecular clock is comprised
of CLOCK (circadian locomotor output cycles kaput)
and BMAL1 (brain and muscle ARNT-like 1) which are
bHLH-PAS transcription factors that bind to an E-box
motif (50-CACGTG-30) as a heterodimer. As part of the
molecular clock, CLOCK and BMAL1 activate transcrip-
tion of factors that constitute the negative loop of
the molecular clock, including the Period (Per) and
Cryptochrome (Cry) gene isoforms Per1, Per2, Cry1 and
Cry2. In turn, CRY and PER proteins act together to
inhibit the trans-activation function of CLOCK and
BMAL1 and this mechanism oscillates over an approxi-
mate 24 h cycle (12,13). Consistent with the feedback
mechanism, the circadian phase of Bmal1 expression was
in anti-phase to circadian phase of Per1/2 and Cry1/2
expression (14–17).
The purpose of the current study was to determine
whether the CE is the module through which the molecu-
lar clock is regulating the circadian expression of MyoD.
In addition, we wanted to identify the cis-acting sites
[E-box(es)] within the CE that bind CLOCK and
BMAL1. In this study, we provide evidence showing
that the MyoD CE is necessary for circadian oscillation
of MyoD expression in vivo. We also show that the CE is
sufficient to confer circadian expression in vitro. We
identify a previously unknown non-canonical E-box in
the MyoD CE that mediates CLOCK and BMAL1
binding and using an in vitro circadian assay we demon-
strate that this non-canonical E-box is required for oscil-
lation of a MyoD reporter. Expression profiling of muscle
from adult CEloxP/loxP mice identified mis-expressed genes
that overlap with MyoD target genes from ChIP-Seq
studies and also disrupted genes identified from analysis
of muscle from the ClockD19 mouse (18). Further experi-
ments indicated that mitochondrial respiration was
impaired in the CEloxP/loxP muscle. These findings
support a model in which the molecular clock factors
directly regulate MyoD expression in skeletal muscle
through regulation of a non-canonical E-box in the CE
and that loss of circadian expression of MyoD contributes
to downstream changes in the expression of MyoD target
genes with effects on mitochondrial function.
MATERIALS AND METHODS
Animals
All animal procedures were conducted in accordance with
institutional guidelines for the care and use of laboratory
animals as approved by the University of Kentucky
Institutional Animal Care and Use Committee. Mice
(C57BL/6J strain) were purchased from The Jackson
Laboratory. The MyoD core enhancer knockout strain
(CEloxP/loxP mice) was originally developed and described
by Chen and Goldhamer in 2004 (10). These mice are
germline knock-outs for the CE so no further breeding
is required. We bred the original CEloxP/loxP mice onto a
C57BL/6J background by backcrossing for 10 gener-
ations. The CEloxP/loxP mice pups were genotyped by
PCR as described by (10). The CEloxP/loxP mouse was
also crossed with Per2::Luc knock-in mice (19) to
produce homozygous mice harboring both CEloxP/loxP
and Per2::Luc.
Circadian tissue collection
We followed the established protocol in the circadian field
for collection of tissues for circadian analysis (18,20).
Briefly, mice (10–12 weeks of age) were entrained to
a 12 h light/12 h dark (12L:12D) cycle for 2 weeks and
then placed in total darkness for 30 h prior to the start
of the tissue collection to remove any light cues. Tissues
were collected in darkness with red light from mice
(n=three/genotype) every 4 h for 32 h (nine time
points). By circadian convention, the onset of activity
for a nocturnal animal is defined as circadian time
12 (CT12) so the first collection was performed at CT18.
Cell culture
The mouse myogenic cell line C2C12 was obtained from
ATCC (CRL 1722). Myoblasts were grown in Dulbecco’s
modified Eagles medium (DMEM; Invitrogen, Carlsbad,
CA, USA) supplemented with 10% fetal bovine serum
and penicillin–streptomycin in a humidified incubator at
37C under 5% CO2. To establish stable clones, C2C12
cells (5 104) were co-transfected with 1 mg of a particular
reporter gene plasmid and 1 mg of pCI-neo plasmid
(Promega, Madison, WI, USA). Stable clones (n=3/
construct) were selected following treatment with G418
at 600 mg/ml and maintained in culture with 200 mg/ml.
Transient transfection
C2C12 cells were transiently transfected with expression
vectors for Clock and Bmal1 (200 ng/vector) and one of
the MyoD reporter genes (50 ng) using Fugene 6 reagent
according to the manufacturer’s instructions (Roche,
Indianapolis, IN, USA) (21). Five ng of pRL Renilla
Luciferase vector (Promega) was co-transfected to
control for transfection efficiency. When necessary, an
empty pGEM plasmid was used to equalize the total
amount of DNA transfected. Cells were collected 24–
48 h after transfection and luciferase activity was
determined using Dual Luciferase Assay System according
to the manufacturer’s instructions (Promega).
In vitro circadian assay
Serum shock was used to synchronize molecular clock in
C2C12 myotubes in vitro using a method previously
described (22,23). Briefly, C2C12 myoblasts were grown
to confluence and then switched to differentiation medium
(DM) consisting of DMEM supplemented with 2% horse
serum. DM was changed every 48 h. After 5 days in DM,
C2C12 myotubes were treated with 50% horse serum for
2 h, washed with phosphate buffered saline (PBS) and
switched to DMEM supplemented with 2% horse serum
for the duration of the experiment. At selected time points
following serum stimulation, cells were washed with cold
PBS and total RNA was isolated from cells using TRIzol
reagent (Invitrogen).
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MyoD reporter genes
Based on our finding that the CE and not the DRR were
bound by CLOCK:BMAL1 we generated a MyoD
luciferase reporter gene lacking the DRR (CE-4.7MyoD)
using the CE-6.8MyoD:luciferase as a template (4).
Approximately 4.7 kb of MyoD upstream 50-flanking
sequence was cloned into the pGL3 basic vector
(Promega) to replace the 6.8 kb fragment in the
CE-6.8MyoD:luciferase reporter. The CE region was
amplified from mouse genomic DNA and was subsequent-
ly inserted upstream of 4.7 kb sequence to produce
CE-4.7MyoD:luciferase reporter gene. The primers used
for amplification of the 4.7 kb flanking sequence (4566
to+103) were 50-CACAAGTGGTTTGAAGTGCTTC-30
(forward) and 50-AGGTTCTGTGGGTTGGAATG-30
(reverse). The primers for amplifying the CE were 50-AA
TGCCCAAAGAGTGGCAGA-30 (forward) and 50-CCA
ATCTCAAAGCCCTGGA-30 (reverse). The DNA
sequence of the reporter gene was verified by sequencing.
Mutagenesis
To create the mutant CE-4.7MyoD:luciferase reporter
gene (CEmt-4.7MyoD), mutagenesis was performed
with plasmid CE-4.7MyoD:luciferase using GeneEditor
in vitro Site-Directed Mutagenesis System (Promega).
The sequence of the oligonucleotide used for mutagenesis
of the non-canonical E-box of the MyoD CE was 50-ATC
TCCCAGAGTGCTGCGCTTAAAACCCGTG-30 with
the underlined sequence indicating the position of the
E-box and the bold letters indicating the mutated bases.
The successful mutation of the non-canonical E-box was
verified by sequencing.
Real-time PCR
To analyze gene expression levels, 1 mg of RNA was
reverse-transcribed to cDNA using Superscript III First
Strand Synthesis system (Invitrogen). Real-time PCR
was performed using Power SYBR Green PCR Master
mix (Applied Biosystems, Carlsbad, CA, USA). The
PCR conditions were as follows: 10min at 95C, 15 s at
95C, 60 s at 60C and 15 s at 95C. The mRNA levels of
target genes were normalized to the corresponding level of
Rpl26 mRNA. The following primers were used: Rpl26,
50-CGAGTCCAGCGAGAGAAGG-30 and 50-GCAGTC
TTTAATGAAAGCCGTG-30; Bmal1, 50-GCAGTGCCA
CTGACTACCAAGA-30 and 50-TCCTGGACATTGCA
TTGCAT-30; Per2, 50-GGCTTCACCATGCCTGTT
GT-30 and 50-GGAGTTATTTCGGAGGCAAGTGT-30;
MyoD, 50-ATGGATTACAGCGGCCCC-30 and 50-TGT
GGAGATGCGCTCCACTA-30. The specificity of each
PCR product was analyzed by electrophoresis and
melting curve.
DNA mobility shift assay
Bmal1 and Clock expression plasmids were transfected
into C2C12 cells and nuclear extracts were prepared as
previously described (24). DNA duplexes were synthesized
for each of the five E-boxes in the MyoD CE. The
sequence for each oligonucleotide was as follows:
E-box-1, 50-GAGCCCCACAGCA TTTGGGGGCATT
TATG-30; E-box-2, 50-GTAT CCTCCTCCAGCAGCTG
GTCACAAAGC-30; E-box-3, 50-CACAACACAGCCAG
TTGGGGGAAGGGG-30; E-box-4, 50-GCGCCCAGA
GTCAGCT GTTCCTGGGTCTTC-30; the non-canonical
E-box, 50-CCCAGAGTGCTCAGCTTAAAACCCG
TGAC-30; the non-canonical E-box mutant, 50-CCCAG
AGTGCTGCTAGGAAAACCCGTGAC-30 (25). The
underlined sequences indicate the position of E-boxes.
Duplexes of these DNA oligonucleotides were 50-end
labeled with 32P-g-ATP using T4 polynucleotide kinase
(Promega). DNA mobility shift assays were performed
as previously described (26). For super-shift experiment,
CLOCK(Abcamab3517)andBMAL1Ab(Abcam,ab3350)
were used. The protein–DNA complexes were resolved on
a 5% polyacrylamide gel with 0.4Tris/Borate/EDTA.
The images were obtained using a PhosphoImager and
scanned using Storm Scanner 860.
Bioluminescent analysis of circadian expression in vitro
Stable clones of C2C12 cells (n=3/construct) were estab-
lished with luciferase based reporter genes containing
either the Bmal1 promoter, CE-4.7MyoD or the CE
non-canonical E-box mutant CEmt-4.7MyoD promoter.
The mouse Bmal1 promoter–luciferase reporter vector
was kindly provided by Dr J. Hogenesch (University of
Pennsylvania) (27). These reporter genes were individually
co-transfected with pCI-neo plasmid into C2C12 myoblast
cells. Three selected stable clones for each reporter
gene were grown in 35mm dishes to confluence and
differentiated for 5 days in DM. Serum shock is a
standard technique used in the circadian field to synchron-
ize the molecular clocks in vitro (28–31). In this study,
myotubes were serum shocked and then incubated in
recording medium which contained 0.1mM luciferin in
phenol red free DMEM with 2% horse serum as previous-
ly described (32). Bioluminescence was measured at 10min
intervals for 4 days using the Lumicycle (Actimetrics Inc.,
Evanston IL) (32). Both raw and baseline subtracted data
were analyzed for circadian characteristics including
period and phase using Lumicycle Analysis software.
The period length of luminescence for each reporter gene
was calculated based on the distances between peaks or
troughs over the 24–60 h post-serum shock from the same
three clones. For these studies, the phase of expression
is defined as the time of the first peak 24 h after serum
shock. For the bioluminescent studies of muscle tissue,
mPER2::LUC homozygous mice were sacrificed by
cervical dislocation. Intact soleus muscles were dissected
out and incubated in recording medium which contained
0.1mM luciferin in phenol red free DMEM with 5% fetal
bovine serum. Results from the luminescence data (period,
phase) were analyzed as described above.
Microarray
For the microarray experiments, we collected gastrocne-
mius muscles from the CE knockout and wild-type mice
(n=three/genotype/time point) at four time points
(CT26, CT30, CT38 and CT42). Total RNA was
isolated from each muscle using the TRIzol reagent
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(Invitrogen) as previously described (18,20). RNA integ-
rity was analyzed using Agilent 2100 Bioanalyzer. For this
study, we wanted to determine differences in gene expres-
sion and not circadian expression so samples for the array
were generated with equal amounts of total RNA/
genotype pooled from the CT26 and CT30 samples, or
from the CT38 and CT42 samples with each pooled
sample analyzed by a separate Affymetrix chip (430 2.0).
For each probe set, we calculated the average expression
for the two chips from each genotype. To identify differ-
entially expressed genes we set a cutoff of more than
400 intensity and either a >2-fold increase or >50%
decrease in expression between the CEloxP/loxP and
wild-type probe sets.
Mitochondrial preparation and measurement of
mitochondrial respiration
Skeletal muscle mitochondria were isolated using isolation
buffer (215mM mannitol, 75mM sucrose, 0.1% BSA,
20mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), 1mM EGTA and pH is adjusted to 7.2
with KOH) at 4C as describe earlier (33).
Mitochondrial respiration was performed using a mini-
ature Clark-type electrode (Hansatech Instruments,
Norfolk, UK) in a sealed, thermostatically controlled
chamber at 37C as described previously (34). Briefly,
oxymetric traces were taken by addition of mitochondria
to yield a final concentration of 200–300 mg protein/ml
respiration buffer (125mM KCl, 2mM MgCl2, 2.5mM
KH2PO4, 20mM HEPES and 0.1% BSA, pH 7.2).
Mitochondrial respiration is initiated by addition of the
Complex I, Nicotinamide adenine dinucleotide (NADH)-
linked oxidative substrates pyruvate and malate (State 2
respiration). This is followed by addition of ADP which
causes flow of protons through the ATP synthase (State 3
respiration) as the added ADP is phosphorylated to ATP.
Mitochondria enter State 4 respiration as all the added
ADP has been phosphorylated (oligomycin, an inhibitor
of the ATP synthase is added to ensure that no protons
cross the inner membrane via the ATP synthase).
Complex I-State 5 respiration is initiated by the addition
of carbonyl cyanide-p-trifluoromethoxyphenylhydrazone,
which acts as a protonophore that collapses the proton
gradient and result in maximum electron transport and
NADH-driven respiration (Complexes I–IV assessed); to
assess Complex II, FADH-linked respiration, the
Complex I inhibitor rotenone is added to the chamber
which completely stops Complex I electron transport
and NADH-driven respiration, and the Complex II sub-
strate succinate is added to the chamber to assess
Complexes II, III and IV (Succ-State 5). Respiration
rate was calculated as nanomoles of oxygen consumed/
min/mg of mitochondrial protein. Two independent
oxymetric traces for each sample were taken and respir-
ation rates were averaged to yield n=1/sample.
Statistical analysis
Data are reported as mean±SEM. To determine if a
significant difference existed between treatment and/or
groups, one-way ANOVA was performed followed by
the Tukey post-hoc test to identify specific significant
differences between means. Differences between groups
were considered significant if P 0.05. For circadian
analysis of gene expression, we used the JTK_CYCLE
program (35). JTK_CYCLE is a non-parametric algo-
rithm developed to determine whether a gene expression
pattern can be considered circadian and if so, it will
provide an objective analysis of phase and period length.
RESULTS
The MyoD CE is required for circadian expression of
MyoD in vivo
Previously, we showed that BMAL1 and CLOCK bind to
the MyoD CE but not the MyoD DRR, suggesting the CE
might be necessary for circadian expression of MyoD (4).
To test this prediction, we determined the expression
of MyoD in adult skeletal muscle of the CEloxP/loxP
mouse (10). To allow for comparison with our initial
study describing the circadian expression of MyoD,
the CEloxP/loxP mice were backcrossed to C57BL/6J for
10 generations to produce a congenic strain that is
considered to be 99.9% C57BL/6J background. These
backcrosses were necessary to ensure any differences
observed in the temporal pattern of MyoD expression
could be attributed to the loss of the CE and not genetic
background. Since little is known about the behavior
of the adult CEloxP/loxP mice, we carried out a series of
experiments to characterize the strain before analyzing
circadian gene expression. There was no difference in
either body weight or muscle weight in comparison to
wild-type C57BL/6J mice (data not shown). Analysis of
circadian behavior found that adult CEloxP/loxP mice
exhibited normal behavior as assessed by wheel running
activity (36) under 12L:12D and free running conditions
12D:12D (Supplementary Figure S1). Under free running
conditions, CEloxP/loxP mice had an average period length
of 23.75±0.28 h compared to 23.57±0.37 h period
length for wild-type C57BL/6J mice (Supplementary
Figure S1).
Next, we compared the circadian expression of core
clock factors, Bmal1 and Per2 in tibialis anterior (TA)
muscles of the CEloxP/loxP and wild-type mice. To be
consistent with previously published circadian gene
expression studies, skeletal muscle collection started 30 h
after the lights had been turned off, corresponding to
CT18 (18,20). First we examined expression of Bmal1
and Per2 mRNA in the muscles of the wild-type
mice every 4 h over 32 h (9 time points). As shown in
Figure 1A, Bmal1 mRNA (empty circle) levels oscillated,
peaking at CT22 and CT50, and Per2 mRNA (filled
triangle) oscillated anti-phase to Bmal1 with peak expres-
sion at CT38. Next we determined Bmal1 and
Per2 mRNA in the muscle of the CEloxP/loxP mice
(Figure 1C). As shown in Figure 1C, expression of
Bmal1 (empty circle) and Per2 (filled triangle) mRNAs
are oscillating across time points however, the amplitude
of expression was slightly lower. To statistically evaluate
the circadian pattern of gene expression in the muscle of
wild-type and CEloxP/loxP mice, we used the JTK_CYCLE
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program (35). Using this analysis, we confirmed that
Bmal1 and Per2 in both wild-type and the CE KO
mice muscle were expressed in a circadian manner with
P< 0.05 (Supplementary Table S1).
To more rigorously evaluate molecular clock function
in the muscle of CEloxP/loxP mice we employed real-time
bioluminescent analysis using the Lumicycle (Actimetrics).
Previous studies have shown that the bioluminescence
rhythm obtained from tissue explants from the circadian
reporter Per2::Luc mouse matches endogenous PER2
protein in vivo (19,32,37). We crossed the CEloxP/loxP
mice with Per2::Luc mice and produced homozygous
mice harboring both the CEloxP/loxP and Per2::Luc. For
these studies both Per2::Luc and the Per2::LucCEloxP/
loxP mice were entrained for 2 weeks. At that time, the
mice were sacrificed and soleus muscles were collected
and placed in culture with recording media plus luciferin
and real-time bioluminescence was recorded every 10min
for 4 days. The power of this experimental approach for
circadian analysis is that it allows us to follow PER2 ex-
pression for each sample over a longer period of time with
much higher temporal frequency (once every 10min versus
tissue collections every 4 h). The increased sampling fre-
quency and longer duration permits a more robust
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Figure 1. Circadian oscillation of MyoD mRNA is dampened in skeletal muscle tissues of the CEloxP/loxP mouse. Adult C57BL/6 J and CEloxP/loxP
mice were entrained to 12 h light/12 h dark conditions for 2 weeks. Thirty hours after lights were turned off (CT18), TA muscles were collected every
4 h from CT18 to CT50. Transcript levels were determined by RT–PCR. Bmal1, Per2 and MyoD mRNA levels were normalized to Rpl26 mRNA
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the graphs represent the mean values±SEM of raw data for five animals. (C) Bmal1 and Per2 expression in CEloxP/loxP mice TA muscle;
(D) Luminescence recordings from Per2::LucCEloxP/loxP soleus muscles. The data for the graphs represent the mean values±SEM of raw data
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For each respective gene, one-way ANOVA followed by Tukey’s post-hoc test was performed to determine significant differences across all time
points. For circadian analysis of gene expression, the JTK_CYCLE program was used.
Nucleic Acids Research, 2012, Vol. 40, No. 8 3423
quantitative analysis of circadian expression with the
capacity to more precisely define important characteristics
including period length and phase.
Raw data are presented in Figure 1B (Per2::Luc)
and Figure 1D (Per2::LucCEloxP/loxP) represent the
mean±SEM luminescence recordings averaged for all
five explants per genotype. Compared to Per2::Luc, the
average level of Per2::LucCEloxP/loxP bioluminescence is
slightly reduced. However baseline subtracted data are
basically the same for Per2::Luc and the
Per2::LucCEloxP/loxP tissues (Supplementary Figure
S2). Analysis of circadian parameters determined that
there were no significant differences for either the period
length (Figure 1F) or the phase between the muscles
from Per2::LucCEloxP/loxP and the Per2::Luc.
Once we confirmed the molecular clock functions
properly in the muscle of the CEloxP/loxP mice we tested
whether loss of the CE affects expression of MyoD
mRNA. Consistent with our previous findings in the
gastrocnemius muscle, MyoD mRNA levels oscillated in
the TA muscle of wild-type mice with peak expression
from CT38 to CT46 (Figure 1E, filled circle) (4).
We then examined expression of MyoD mRNA in
the TA muscle of the CEloxP/loxP mice. As illustrated in
Figure 1E (empty circle), the expression pattern of MyoD
mRNA was significantly dampened. Analysis of MyoD
expression using JTK_CYCLE confirmed that expression
was oscillating in a circadian manner in the wild-type mice
but was not circadian in the muscle of the CEloxP/loxP mice.
These results confirm that the CE is necessary for circa-
dian expression of MyoD in vivo. We also noted that while
expression of MyoD in the CEloxP/loxP mice was reduced
compared to wild-type across most time points there was
no difference in expression between the two genotypes at
the trough of MyoD expression, CT34 suggesting that
the lower expression of MyoD reported previously
maybe more related to time of analysis.
The non-canonical E-box in the MyoD CE is required
for BMAL1 and CLOCK Binding and activation
The nucleotide sequence of the CE is highly conserved
across mouse, rat and human genomes (89–98%).
There are four canonical E-boxes (50-CANNTG-30) in
the MyoD CE as previously described (13,38). The canon-
ical E-box sequences from upstream to downstream are C
ATTTG (E1), CAGCTG (E2), CAGTTG (E3) and CAG
CTG (E4) (Supplementary Figure S3). All four E-boxes
are identical in the rat and mouse whereas only E-boxes
E2 and E4 are conserved in human. In addition to these
four canonical E-boxes, there was one non-canonical
E-box (50-CAGCTT-30) that is located between E2 and
E3 (indicated by hash). The sequence of the non-canonical
E-box and its flanking sequences are conserved
across mouse, rat and human MyoD CE sequences
(Supplementary Figure S3). Interestingly, the non-
canonical E-box is similar to the BMAL1:CLOCK
binding site (50-CACGTT-30) found within the promoter
of the core clock gene Per2 (39).
Our previous work demonstrated that BMAL1 and
CLOCK can bind to the MyoD CE using chromatin
immunoprecipitation assays with nuclear extracts from
mouse adult skeletal muscle (4). In order to determine if
CLOCK and BMAL1 proteins were capable of binding
any of the aforementioned E-boxes we performed electro-
phoretic mobility shift assay (EMSA) experiments.
The binding reaction contained one of four different
E-box oligonucleotide probes and nuclear extracts
derived from C2C12 myoblasts that were transfected
with Bmal1 and Clock expression plasmids. Figure 2A
shows representative images from EMSA using each
of the canonical E-box probes. For each probe,
protein:DNA complexes were detected and shown to be
specific as indicated by successful competition with excess
cold oligonucleotide competitor (Figure 2A). While the
protein:DNA complexes were specific, none of these
complexes contained CLOCK as incubation with a
CLOCK antibody failed to deplete or super-shift the
observed protein:DNA complexes.
We next tested whether the non-canonical E-box
located between E2 and E3 within the CE was capable
of binding CLOCK and/or BMAL1. Figure 2B shows
that the non-canonical E-box formed a protein:DNA
complex that contained both CLOCK and BMAL1. The
addition of either CLOCK (left panel) or BMAL1 (middle
panel) antibody to the binding reaction was able to
prevent formation of the protein:DNA complex whereas
addition of control IgG did not alter binding. The speci-
ficity of the E-box for CLOCK and BMAL1 binding was
further confirmed by mutagenesis. EMSA performed with
a mutated form of the non-canonical E-box resulted in
two binding complexes that were not altered by addition
of either the CLOCK antibody or the BMAL1 antibody to
the binding reaction (Figure 2B, right panel). Taken
together, these results demonstrate that CLOCK and
BMAL1 bind to the non-canonical E-box in theMyoDCE.
The EMSA results demonstrated that both CLOCK
and BMAL1 bind to the non-canonical E-box (50-CAGC
TT-30) so our next set of experiments tested whether this
E-box was functional in vitro. We generated the reporter
construct, CEmt-4.7MyoD:luciferase and performed
transient co-transfection experiments in C2C12 cells. We
found that transfection of the CE-4.7MyoD:luciferase
reporter gene with Clock plus Bmal1 expression vectors
resulted in a 2.5-fold increase of CE-4.7MyoD:luciferase
expression (Figure 2C). In contrast, over-expression of
both Clock and Bmal1 did not result in an activation
of the CEmt-4.7MyoD:luciferase reporter gene. We
concluded from these transfection experiments that the
non-canonical E-box within the CE is functional and
required for full activation of MyoD reporter by
BMAL1 and CLOCK.
The MyoD CE is required for circadian expression of the
MyoD reporter gene in C2C12 myotubes
Having established that the CE is required for MyoD
oscillation in vivo, and that the non-canonical Ebox
binds CLOCK and BMAL1, we next wanted to determine
whether this E-box could confer circadian oscillation
using an in vitro assay. This required the validation of a
serum shock cell culture model for evaluating molecular
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clock factor expression in C2C12 muscle cells. Serum
shock is commonly used to synchronize molecular clocks
across cells in vitro. This is necessary to allow for objective
analysis of circadian gene expression taking into account
the proper pattern (cosinar) and temporal oscillations
(24 h). To determine whether serum stimulation is suffi-
cient to synchronize circadian gene expression in C2C12
myotubes we evaluated expression of Bmal1 mRNA using
real-time PCR. Myotube cultures were serum shocked and
samples were collected every 6 h for 54 h. As shown in
Figure 3A, Bmal1 mRNA expression varies over time
following serum stimulation. We found that the peak
and trough expression of Bmal1 mRNA was separated
by 12 h (18 versus 30 h, 30 versus 42 h) and the difference
in expression between peak and trough was statistically
significant (P< 0.05). Likewise, endogenous MyoD
mRNA expression showed an oscillation in expression
with the peak and trough levels occurring 12 h apart
(Figure 3B). In addition, the pattern of Bmal1 and
MyoD oscillations were anti-phase and this is similar to
the pattern observed in vivo and consistent with MyoD
expression being regulated by the clock factors, BMAL1
and CLOCK (4). Use of JTK-CYCLE software also con-
firmed these observations that expression of endogenous
Bmal1 and MyoD mRNAs in myotubes following
serum shock were circadian (Supplementary Table S2).
To more quantitatively evaluate the necessity of the
non-canonical E-box for the circadian expression of
MyoD, we employed real-time bioluminescent analysis
using the Lumicycle. For this set of experiments, we
generated stable C2C12 cells lines containing either the
Bmal1:luciferase reporter gene, CE-4.7MyoD:luciferase
reporter gene or CEmt-4.7MyoD:luciferase reporter
gene. C2C12 stable clones (n=three/reporter) were
differentiated into myotubes for 5 days and serum
shocked as previously described. The medium was then
replaced with non-phenol red DMEM containing luciferin
plus 2% horse serum. Light emission was captured at
10min intervals in real time using the Lumicycle for
4 days. Raw data for each clone was baseline subtracted
and the data for the graphs in Figure 4 represent the mean
values±SEM for three independent clones for the
reporter gene.
We first evaluated expression of the Bmal1 reporter
gene in C2C12 myotubes. Consistent with our real-time
PCR analysis (Figure 3A), the results of these experiments
showed that the Bmal1 promoter directs circadian expres-
sion of luciferase (Figure 4A). As seen in Figure 4, the
circadian amplitude damped gradually with time resulting
from the depletion of nutrients and luciferin as replace-
ment with fresh medium was able to restore the amplitude
(data not shown).
Next, we tested whether the CE-4.7MyoD:luciferase
reporter gene directed circadian expression. As shown in
Figure 4B, there was a robust oscillation. In contrast,
the CEmt-4.7MyoD:luciferase reporter gene expression
(Figure 4C) was greatly dampened. JTK analysis
determined that Bmal1:luciferase and CE-4.7MyoD:
luciferase were circadian, but CEmt-4.7MyoD:luciferase
was not expressed in a circadian manner (Supplementary
Table S2). These results provide further evidence that the
non-canonical E-box is the cis-regulatory element within
the CE that confers circadian rhythmicity to the MyoD
promoter.
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Figure 2. The non-canonical E-box of the MyoD CE is required for
CLOCK and BMAL1 binding and activation of the MyoD promoter
by BMAL1: CLOCK. EMSA analysis of CLOCK and BMAL1 binding
at the E-boxes located within the MyoD CE was performed with
nuclear extract derived from C2C12 cells over-expressing Clock and
Bmal1 and an oligonucleotide probe containing one of the five CE
E-boxes. (A) The DNA:protein complexes formed using a probe
containing one of the canonical E-boxes (E1, E2, E3 or E4). (B) The
DNA:protein complexes formed using the non-canonical E-box and the
mutant of the non-canonical E-box. The arrow indicates the specific
DNA:protein complex that contained CLOCK and BMAL1.
(C) A wild-type (CE-4.7MyoD:luciferase) or mutant (CEmt-
4.7MyoD:luciferase) reporter gene construct was transiently
co-transfected with Clock plus Bmal1 expression plasmids into C2C12
myoblasts. Luciferase activity was measured 24–48 h later. The histo-
gram displays the results from three independent experiments with
values presented as mean±SEM. A one-way ANOVA test indicated
CE-4.7MyoD:luciferase reporter gene activation by CLOCK plus
BMAL1 (empty bar) was significantly greater than control (gray bar)
denoted by asterisks.
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Differentially expressed genes in skeletal muscle of the
CEloxP/loxP mice are also mis-expressed in the Clock"19
mutant muscle
Similar to the CEloxP/loxP mice, we previously reported a
loss of MyoD circadian expression in the Clock19 mutant
strain and the Bmal1 knockout strain (4,18). The
mis-expression of MyoD in skeletal muscle of Clock19
mutant was associated with the down-regulation of
muscle-specific genes, many of which are known MyoD
target genes. To determine if a comparable response in
gene expression occurred in the muscle of CEloxP/loxP
mice, we performed a microarray analysis of RNA from
gastrocnemius muscles of adult mice. Using the criteria
(either 2-fold increased or 50% decreased) outlined
in ‘Materials and Methods’ section, we identified 1271
genes that were differentially expressed between
wild-type and CEloxP/loxP muscle with 84% of the genes
showing decreased expression in the CEloxP/loxP
(Supplementary Table S3, in black). Gene ontology clas-
sification using DAVID (http://david.abcc.ncifcrf.gov/)
revealed enrichment for genes related to contractile fiber
(30 genes), endoplasmic reticulum (105 genes), cytosol (70
genes) and mitochondrion (134 genes) (Supplementary
Table S6A). The expression of a number of skeletal
muscle-specific genes were down-regulated in the muscle
of the CEloxP/loxP mice including alpha actinin 3 (Actn3),
titin (Ttn), dihydropyridine receptor, calcium channel,
voltage-dependent calcium channel (Cacnb1) and calpain
3 (Capn3).
We next interrogated a ChIP-Seq derived MyoD target
database to determine whether any of the mis-expressed
genes were MyoD target genes (40). This analysis
identified 461 genes (36.3%) that were scored as MyoD
target genes according to the ChIP-Seq database
(Supplementary Table S4). Among the 461 genes, Gene
ontology classification using DAVID revealed enrichment
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Figure 3. Serum shock is sufficient to synchronize circadian gene expression in C2C12 myotubes. Stable clones of C2C12 cells (CE-4.7MyoD) were
differentiated for 5 days prior to serum shock. RNA was isolated at the indicated time post-serum shock and used to determine the expression level
of Bmal1 and MyoD by RT-PCR. The target transcript levels were normalized to Rpl26 transcript levels and then normalized to the highest point
across all time points. The data for the graphs represent the mean values±SEM for three independent clones for the reporter gene. The expression
of endogenous Bmal1 (A), endogenous MyoD (B) all displayed a circadian oscillation as indicated by significant differences in peak and trough
expression. For each respective gene, one-way ANOVA followed by Tukey post-hoc test identified significant difference (P< 0.05) between peak
expression and other time points as indicated by an asterisk. For circadian analysis of gene expression the JTK_CYCLE program was used.
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Figure 4. Mutation of the MyoD CE non-canonical E-box disrupts circadian oscillation in bioluminescent assay. Stable clones of C2C12 cells
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independent clones for each reporter. For circadian analysis of gene expression, the JTK_CYCLE program was used.
3426 Nucleic Acids Research, 2012, Vol. 40, No. 8
for genes related to sarcomere (13 genes), cytosol
(35 genes) and mitochondrion (59 genes) (Supplementary
Table S6B).
We also interrogated the differentially expressed genes
from the CEloxP/loxP data set versus the data set reported
for the Clock19 skeletal muscle (18). This analysis
revealed that 207 genes altered in the muscle of
the CEloxP/loxP mice are also altered in Clock19 mice
(Supplementary Table S5). Among the 207 genes, we
found 177 (86%) genes (Supplementary Table S5, in
black) are down-regulated. Gene ontology classification
using DAVID revealed enrichment for genes related to
sarcomere (seven genes), cytosol (17 genes) and mitochon-
drion (26 genes) (Supplementary Table S6C). The
overlapping genes include several muscle specific genes,
for example, Myl3, Myo18a, Ttn, Tpm1, Tpm2, Myoz2
and Myom2 (Supplementary Table S5). These results
suggest that genes differentially expressed in the muscle
of the CEloxP/loxP mice could be downstream of the
BMAL1:CLOCK toMyoD circadian transcriptional loop.
Respiratory function is reduced in the mitochondria
isolated from muscle of CEloxP/loxP mice
The gene ontology analysis indicated that many genes
related to mitochondria are altered in the CEloxP/loxP
mouse muscle. We analyzed the respiratory function of
mitochondria isolated from 5- to 6-month-old wild-type
versus CEloxP/loxP mice to determine whether the changes
in gene expression were associated with any functional
effect. As shown in Figure 5, we found no significant
differences in States 2, 3 and 4 respiration rates between
wild-type and CEloxP/loxP muscle. However, we found that
there was a significant difference in Complexes I and II
driven maximum electron transport (Complex I-State 5
and succinate State 5 respiration rates). Specifically, we
found that both Complexes I and II of State 5 respiration
rates were reduced. In Complex I, NADH dehydrogenase
catalyzes the electron transfer from NADH to
Ubiquinone (Q) and in Complex II succinate dehydrogen-
ase catalyzes electron transfer from succinate to
Ubiquinone (Q) via FAD. The changes in respiration
were consistent with our data from expression analysis
as level of Sdhc mRNA, which encodes a subunit of
succinate dehydrogenase is down-regulated by 67% in
the CEloxP/loxP muscle. These findings demonstrate that
loss of the CE of MyoD is associated with a disruption
in mitochondrial function.
DISCUSSION
The main finding from this study was the identification of
a novel non-canonical E-box in the CE of the MyoD
promoter that is necessary for CLOCK:BMAL1 binding
and confers circadian expression. The deletion of the CE
abolished circadian expression of MyoD mRNA in vivo
and transfection assays demonstrated that mutation of
the E-box abolished the circadian expression in vitro. Of
the E-boxes located within the CE, only the non-canonical
E-box was capable of binding the core clock factors
CLOCK and BMAL1. However, previous studies have
shown that the canonical E-boxes in the CE are required
for MyoD expression in developing skeletal muscle (9).
Conclusions from this work were that the E-box 1
region is essential for basal MyoD expression while the
E-box 4 region defines the CE as a target for Myf5-
dependent activation of MyoD in myotomal muscle.
Thus, our current findings expand the role of the CE in
the regulation of MyoD expression to include BMAL1
and CLOCK binding and activation in adult skeletal
muscle.
The finding that CLOCK and BMAL1 are capable of
binding to a non-canonical E-box (50-CAGCTT-30) within
the CE is not without precedent as these factors have been
shown to bind a range of different E-box sequences
(41,42). For instance, the CLOCK:BMAL1 heterodimer
has been shown to regulate the circadian expression of
Per1 via a canonical E-box (50-CACGTG-30) while
analysis of the promoter of the clock-controlled gene,
Dbp, demonstrated BMAL1 and CLOCK binding at
multiple E-boxes, including one non-canonical E-box
important for circadian expression (26). In Per2, the
BMAL1: CLOCK heterodimer binds to an E-box-like
sequence (50-CACGTT-30) that was shown to be sufficient
and indispensable for the circadian oscillation of Per2
expression (39,43). The same non-canonical E-box was
also shown to have circadian function in another clock-
controlled gene, bHLH family member e41 (Bhlhe41) (44).
In cryptochrome 1 (Cry1), a 47 bp DNA fragment
containing a canonical E-box and a non-canonical
E-box, both E-boxes were required and sufficient to
drive Cry1 circadian expression with the appropriate
phase (38,44). Collectively, these findings clearly show
that both canonical and non-canonical like E-boxes we
identified in the MyoD CE are commonly found as
targets for BMAL1 and CLOCK binding.
The loss of circadian MyoD expression seen in the
muscle of the CEloxP/loxP mouse clearly demonstrated
that this regulatory region was necessary for conferring
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Figure 5. Respiration rates are lower in the mitochondria of the
CEloxP/loxP than in wild-type. Gastrocnemius muscles from 5- to
6-month-old mice were isolated from wild-type (empty bars) or the
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a circadian pattern of expression in adult muscle. This
finding was somewhat surprising given that previous
studies had shown that the DRR (distal regulatory
region) was the enhancer responsible for regulating
MyoD expression in adult skeletal muscle (8,11). The
necessity of the CE for the circadian expression of
MyoD, however, was consistent with our previous ChIP
results showing that CLOCK and BMAL1 bound only the
CE, not the DRR, in a diurnal manner (4). However this
does not exclude the possibility that DRR and other
elements within the MyoD promoter, which may also
contribute to proper circadian MyoD expression. The
CE and the DRR enhancers have been shown to exhibit
complementary activities and together are able to recap-
itulate MyoD expression in developing and mature
skeletal muscle (8,11,45,46,). The molecular mechanisms
are not well defined at this time and future studies will be
required to delineate all the necessary elements that
cooperate to direct the properMyoD circadian expression.
Since circadian MyoD mRNA expression is disrupted in
the CEloxP/loxP mice, we used expression profiling to ask
whether there was an alteration in muscle gene expression
and if so, whether any of the changes were in common
with those defined for the muscle of the Clock19 mouse.
This concept emerged from our earlier work using the
Clock19 mouse in which the loss of MyoD cycling, but
not loss of MyoD expression, was associated with mis-
expression of many muscle-specific genes. Furthermore,
in agreement with the Clock19 findings, the expression
level of some of the same muscle-specific genes (Ttn,
Tpm1, Tpm2, Myom2) were found to be mis-expressed
in the CEloxP/loxP mice. While the downstream conse-
quences of this alteration in MyoD target gene expression
remains to be fully explored, preliminary studies indicate
the muscle from the CEloxP/loxP mice does not phenocopy
the Clock19 in terms of mechanical function (Zhang, X.,
Wolff, G. and Esser, K.A., unpublished data). The reason
for a lack of a muscle phenotype in the CEloxP/loxP mice at
4 months of age remains to be determined but may be an
issue of time and/or age—it may take longer for the
muscle phenotype to emerge in the CEloxP/loxP mice than
in Clock19 mouse. This is a reasonable hypothesis given
that the muscle pathologies seen in the Clock19 mouse
occur in a system in which all cells/tissues exhibit circadian
misalignment due to the mutation in Clock. Future studies
will test whether long-term loss of MyoD oscillation
in the CEloxP/loxP mice leads to downstream alterations
associated with changes in the myogenic expression
program.
Previously, we reported decreased mitochondrial
volume and depressed respiratory function of muscle
from circadian mutant Bmal1 KO and Clock19 mice.
However in MyoD KO mouse muscle, we did not detect
any decrease in mitochondrial volume based on analysis of
electron micrographs (4). In this study, we evaluated
mitochondrial respiration in the muscle of the CEloxP/loxP
mice based on our expression profiling data. We found
a significant reduction in State 5 which is consistent with
the array results but was not what we expected based on
our morphological analysis of mitochondria from the
MyoD KO mouse. One explanation for this difference is
that we did not measure mitochondrial respiration in the
muscle of the MyoD KO mouse, thus while the volume
was unchanged the biochemical capacity was not assessed.
Additionally, previous studies have reported that the loss
of MyoD is compensated by other functionally redundant
genes, such as Myf5, and this could act to preserve mito-
chondrial volume. In the muscle of the CEloxP/loxP mice
we do not see any changes in expression of the other
myogenic regulatory factor family. This leads us to
suggest that circadian expression of MyoD in the adult
mouse is important for the regulation of mitochondrial
function.
In conclusion, we have identified a new function for the
CE of MyoD in adult skeletal muscle. We determined that
the CE was required for MyoD circadian expression
in vivo. We also found that a novel non-canonical E-box
located within the CE was required for the full activation
of MyoD expression as well as its circadian expression.
The loss of the MyoD circadian expression is associated
with significant changes in expression of many MyoD
target genes and disrupted mitochondrial function. These
results provide evidence that the molecular clock in skeletal
muscle is important for daily regulation of myogenic
gene expression and contributes to the maintenance of
mitochondrial/metabolic function of adult skeletal muscle.
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